Sankey It
Loading...
Eli Lilly and Company FY2025 income statement | Sankey It
Sankey It · LLY
Eli Lilly and Company FY2025 income statement
USD · fiscal year ended 2025-12-31
FY2025
FY2024
FY2023
FY2022
FY2021
Quarterly
Annual
comfortable
compact
Hide amounts
Export
Fullscreen
Eli Lilly and Company FY2025 income statement
Flow diagram with 10 nodes and 9 flows for Eli Lilly and Company FY2025 income statement. Values: Product US$61B, Collaboration and Other Revenue US$4.2B, Revenue US$65.2B, Cost of Revenue US$10.6B, Gross Profit US$54.6B, Operating Expenses US$24.9B, Operating Income US$29.7B, Other Expense US$4B, Tax US$5.1B, Net Income US$20.6B.
Product
US$61B
+50% Y/Y
94% of revenue
Collaboration and Other Revenue
US$4.2B
-2% Y/Y
6% of revenue
Revenue
US$65.2B
+45% Y/Y
Cost of Revenue
(US$10.6B)
+25% Y/Y
16% of revenue
Gross Profit
US$54.6B
+49% Y/Y
84% margin
Operating Expenses
(US$24.9B)
+30% Y/Y
38% of revenue
Operating Income
US$29.7B
+70% Y/Y
46% margin
Other Expense
(US$4B)
-18% Y/Y
6% of revenue
Tax
(US$5.1B)
+144% Y/Y
8% of revenue
Net Income
US$20.6B
+95% Y/Y
32% margin
Net / profit
Inputs
Tax / cost
Copy link
Share on X
Open full screen